MHRA Approval for use of Clinical investigation devices

December 16, 2021

Neurotherapeutics Ltd received MHRA approval to use prototype clinical investigation devices in a new clinical study which will start in March 2022.

This study will investigate the impact of median nerve stimulation on reducing tics in individuals with Tourette syndrome.

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.
Medilink Midlands Awards
Back to Top